Mini Review
Accepted on 21 Nov 2025
Next-Generation Immunotherapy for Bladder Cancer: From the BCG Legacy to CAR-T and CAR-NK Cell Therapy "Evolving Frontiers in Bladder Cancer Immunotherapy: Integrating BCG, Immune Checkpoints, Viral Vectors, Nanotechnology, and CAR-Based Therapies"
in Cancer Cell Biology